LAI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 3.461
AS - Asia 2.611
EU - Europa 2.343
SA - Sud America 354
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 162
OC - Oceania 65
Totale 9.213
Nazione #
US - Stati Uniti d'America 3.338
IT - Italia 1.154
SG - Singapore 729
CN - Cina 644
BR - Brasile 282
SE - Svezia 251
HK - Hong Kong 248
VN - Vietnam 184
DE - Germania 164
GB - Regno Unito 156
IN - India 125
TR - Turchia 119
KR - Corea 112
FR - Francia 104
JP - Giappone 103
NL - Olanda 74
CA - Canada 72
FI - Finlandia 66
RU - Federazione Russa 64
BG - Bulgaria 53
AU - Australia 52
CI - Costa d'Avorio 49
IQ - Iraq 37
PH - Filippine 37
PK - Pakistan 37
BD - Bangladesh 36
MX - Messico 35
IR - Iran 34
CH - Svizzera 32
MA - Marocco 31
BE - Belgio 29
NG - Nigeria 29
EG - Egitto 26
MY - Malesia 25
AR - Argentina 24
AT - Austria 22
SN - Senegal 22
TW - Taiwan 22
ZA - Sudafrica 21
IE - Irlanda 20
PL - Polonia 20
PT - Portogallo 19
ES - Italia 17
TH - Thailandia 16
CZ - Repubblica Ceca 15
UA - Ucraina 15
SA - Arabia Saudita 14
ID - Indonesia 13
NZ - Nuova Zelanda 13
GR - Grecia 12
CO - Colombia 11
JO - Giordania 11
UZ - Uzbekistan 11
LT - Lituania 10
DZ - Algeria 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
EC - Ecuador 8
IL - Israele 8
ET - Etiopia 7
HU - Ungheria 7
LV - Lettonia 7
KE - Kenya 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
GH - Ghana 5
LB - Libano 5
PS - Palestinian Territory 5
DK - Danimarca 4
GY - Guiana 4
HR - Croazia 4
RO - Romania 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
GT - Guatemala 3
JM - Giamaica 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
PE - Perù 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CR - Costa Rica 1
CU - Cuba 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 9.036
Città #
Dallas 440
Ashburn 426
San Jose 406
Singapore 397
Hong Kong 212
Santa Clara 203
Milan 132
Chandler 118
Shanghai 104
Pisa 102
Hefei 93
Los Angeles 93
Council Bluffs 90
New York 84
Beijing 77
Florence 77
Rome 77
Fairfield 70
Seoul 66
Tokyo 59
Ho Chi Minh City 56
London 56
Boardman 54
Sofia 51
Woodbridge 51
Abidjan 49
Houston 49
Munich 49
Guangzhou 46
Serra 45
Princeton 42
Seattle 42
Ann Arbor 40
Ankara 39
Helsinki 36
Hanoi 35
Lauterbourg 35
Frankfurt am Main 30
São Paulo 28
Livorno 26
Casablanca 25
Lawrence 25
Wilmington 25
Brisbane 24
Chicago 24
Massa 24
Medford 23
Atlanta 22
Cambridge 22
Dakar 22
Lagos 22
Redondo Beach 22
Baltimore 21
Buffalo 21
Lucca 21
Cascina 20
Montreal 19
San Diego 18
Baghdad 17
Brussels 17
Orem 17
Phoenix 17
Zurich 17
Istanbul 16
Rivalta di Torino 16
Belo Horizonte 15
Chennai 15
Vienna 15
Washington 15
Brooklyn 14
Dublin 14
Genoa 14
Izmir 14
Turku 14
Amsterdam 13
Grosseto 13
Lahore 13
Melbourne 13
Mumbai 13
Santarém 13
Toronto 13
Indianapolis 12
New Delhi 12
Ottawa 12
Bologna 11
Cagliari 11
Cairo 11
Düsseldorf 11
Ogden 11
Warsaw 11
Athens 10
Auckland 10
Bengaluru 10
Bremen 10
Curitiba 10
Da Nang 10
Johannesburg 10
Naples 10
Nuremberg 10
San Giuliano Terme 10
Totale 5.125
Nome #
Viral vectors: a look back and ahead on gene transfer technology 1.321
Evolution of viruses and the emergence of SARS-CoV-2 variants 390
Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells 244
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 239
Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells 196
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine 193
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion. 193
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 192
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib 190
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 190
Zika virus induces FOXG1 nuclear displacement and downregulation in human neural progenitors 189
Broad-spectrum virucidal activity of a hydroalcoholic extract of grape pomace 185
Nanostructured Strategies for Melanoma Treatment—Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity 184
Converting biomass waste into valuable biomaterials and bioactive compounds: an overview of antimicrobial activities in the pursuit of global sustainability and health 180
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model 180
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 178
Surface acoustic wave-based lab-on-a-chip for the fast detection of Legionella pneumophila in water 175
Pcsk9 induces tissue factor expression by activation of tlr4/nfkb signaling 175
Re-evaluation of Tuscan Crocus sativus L. wastes by metabolomic fingerprint and in vitro antiviral test against SARS-CoV-2 174
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats 173
Ablation of acid ceramidase impairs autophagy and mitochondria activity in melanoma cells 172
Enhancing antimicrobial and antiviral properties of Cynara scolymus L. waste through enzymatic pretreatment and lactic fermentation 171
Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin 167
Supercritical CO2 extracts rich in palmitoylethanolamide from Glycine max (L.) Merr. waste and Medicago sativa L. aerial parts 162
Sphingolipid/ceramide pathways and autophagy in the onset and progression of melanoma: Novel therapeutic targets and opportunities 159
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes 158
Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS-CoV-2 infection 153
A low-cost simple test for weekly detection of Mycoplasma hyorhinis and arginini contaminations in cell cultures and viral preparations 152
Effects of Nutraceuticals on Cisplatin-Induced Cytotoxicity in HEI-OC1 Cells 150
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels 149
Viral vectors: a look back and ahead on gene transfer technology. 145
Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor 144
Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia 140
SILENCING MICAL2 REPRESSES HUMAN CANCER CELL GROWTH AND INVASION INDUCING MESENCHYMAL TO EPITHELIAL TRANSITION 135
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses 133
Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets 131
In vivo delivery of Herpes simplex type-1 glycoprotein B by a lentiviral vector affords protection against genital herpes. 128
Integrated opto-fluidic device for high-power living cell exposure and detection 126
Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells 125
Redondovirus DNA in human respiratory samples 124
Sviluppo di un vaccino contro herpes genitalis: analisi di risposta immune ed efficacia protettiva nel modello murino. 122
Lipid balance remodelling by human positive-strand RNA viruses and the contribution of lysosomes 117
Canonical fibroblast growth factors in viral infection 112
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 106
Design, synthesis, and biological screening of a series of 4'-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 105
Fighting RNA viruses with a gold nanoparticle Cas13d gene-editing armor 100
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 83
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 75
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 70
Cell membrane-camouflaged double emulsion-based SNEDDS for targeted melanoma therapy using Inula viscosa 68
Surface-Acoustic-Wave (SAW) Induced Mixing Enhances the Detection of Viruses: Application to Measles Sensing in Whole Human Saliva with a SAW Lab-On-a-Chip 66
Herpes Simplex 2 Virus Depletes Cells of DEAD-Box Helicase 3 Protein by Packaging It into Virions 45
N‐Acylethanolamine Acid Amidase Inhibition Reduces SARS‐CoV‐2 Infection in Human Precision Cut‐Lung Slices and Downregulates NF‐KBB Signalling 37
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study 27
A Pyrido‐Quinoxaline Derivative That Downregulates Reticulon 3 Protein Exhibits Potent Antiviral Activity Against Zika Virus 15
Totale 9.213
Categoria #
all - tutte 24.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022512 0 12 0 26 97 66 81 24 29 23 54 100
2022/2023639 83 87 60 25 55 64 24 29 132 11 50 19
2023/20241.170 45 68 117 110 131 141 114 117 49 84 96 98
2024/20252.385 72 112 72 164 222 227 200 106 214 221 312 463
2025/20263.727 263 386 506 293 302 228 481 154 261 439 193 221
2026/2027304 179 125 0 0 0 0 0 0 0 0 0 0
Totale 9.213